Regeneron Pharmaceuticals has paused critically ill COVID-19 patients’ enrollment

Regeneron Pharmaceuticals has paused critically ill COVID-19 patients’ enrollment with its trial studying the antibody cocktail treatment, which was fond of President Trump earlier this month.

It is amazing how drugs make headway against lung, breast, and prostate cancers

Newer drugs are substantially improving and enhancing the chances of survival for some individuals with hard-to-treat forms of lung, breast, and prostate cancer, doctors, reported at the world’s largest cancer conference. Immunotherapy drugs such as Keytruda have transformed the various treating types of cancerous tumors, but they’re still relatively new and don’t help most patients.Continue reading “It is amazing how drugs make headway against lung, breast, and prostate cancers”